Skip to main content
Top
Published in: BMC Urology 1/2018

Open Access 01-12-2018 | Research article

Changes in renal papillary density after hydration therapy in calcium stone formers

Authors: Pietro Manuel Ferraro, Matteo Vittori, Giuseppe Macis, Alessandro D’Addessi, Gianmarco Lombardi, Claudia Palmisano, Jacopo Gervasoni, Aniello Primiano, Pier Francesco Bassi, Giovanni Gambaro

Published in: BMC Urology | Issue 1/2018

Login to get access

Abstract

Background

Previous studies have shown that, compared with non-stone formers, stone formers have a higher papillary density measured with computer tomography (CT) scan. The effect of increased hydration on such papillary density in idiopathic calcium stone formers is not known.

Methods

Patients with recurrent calcium oxalate stones undergoing endourological procedures for renal stones at our Institution from June 2013 to June 2014 were considered eligible for enrolment. Enrolled patients underwent a baseline unenhanced CT scan before the urological procedure; after endoscopic removal of their stones, the patients were instructed to drink at least 2 L/day of a hypotonic, oligomineral water low in sodium and minerals (fixed residue at 180 °C < 200 mg/L) for at least 12 months. Finally, the patients underwent a follow-up unenhanced CT scan during hydration regimen.

Results

Twenty-five patients were prospectively enrolled and underwent baseline and follow-up CT scans. At baseline, mean papillary density was 43.2 ± 6.6 Hounsfield Units (HU) (43.2 ± 6.7 for the left kidney and 42.8 ± 7.1 HU for the right kidney). At follow-up and after at least 12 months of hydration regimen, mean papillary density was significantly reduced at 35.4 ± 4.2 HU (35.8 ± 5.0 for the left kidney and 35.1 ± 4.2 HU for the right kidney); the mean difference between baseline and follow-up was − 7.8 HU (95% confidence interval − 10.6 to − 5.1 HU, p < 0.001).

Conclusions

Increased fluid intake in patients with recurrent calcium oxalate stones was associated with a significant reduction in renal papillary density.

Trial registration

NCT03343743, 15/11/2017 (Retrospectively registered).
Literature
1.
go back to reference Scales CD, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160–5.CrossRef Scales CD, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160–5.CrossRef
2.
go back to reference Croppi E, Ferraro PM, Taddei L, Gambaro G. Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res. 2012;40:517–22.CrossRef Croppi E, Ferraro PM, Taddei L, Gambaro G. Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res. 2012;40:517–22.CrossRef
3.
go back to reference Ferraro PM, Curhan GC, D’Addessi A, Gambaro G. Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J Nephrol. 2017;30:227-33.CrossRef Ferraro PM, Curhan GC, D’Addessi A, Gambaro G. Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J Nephrol. 2017;30:227-33.CrossRef
4.
go back to reference Saigal CS, Joyce G, Timilsina AR. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68:1808–14.CrossRef Saigal CS, Joyce G, Timilsina AR. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68:1808–14.CrossRef
5.
go back to reference Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115:2598–608.CrossRef Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115:2598–608.CrossRef
6.
go back to reference Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol. 2007;177:31–8.CrossRef Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol. 2007;177:31–8.CrossRef
7.
go back to reference Eisner BH, Iqbal A, Namasivayam S, Catalano O, Kambadakone A, Dretler SP, et al. Differences in computed tomography density of the renal papillae of stone formers and non-stone-formers: a pilot study. J Endourol. 2008;22:2207–10.CrossRef Eisner BH, Iqbal A, Namasivayam S, Catalano O, Kambadakone A, Dretler SP, et al. Differences in computed tomography density of the renal papillae of stone formers and non-stone-formers: a pilot study. J Endourol. 2008;22:2207–10.CrossRef
8.
go back to reference Bhuskute NM, Yap WW, Wah TM. A retrospective evaluation of Randall’s plaque theory of nephrolithiasis with CT attenuation values. Eur J Radiol. 2009;72:470–2.CrossRef Bhuskute NM, Yap WW, Wah TM. A retrospective evaluation of Randall’s plaque theory of nephrolithiasis with CT attenuation values. Eur J Radiol. 2009;72:470–2.CrossRef
9.
go back to reference Baran I, Voyvoda N, Tokgöz Ö, Tokgöz H. Can Hounsfield unit values of the cortex and papillae determined by computed tomography demonstrate the possibility of kidney stone formation? Eur J Radiol. 2012;81:1446–9.CrossRef Baran I, Voyvoda N, Tokgöz Ö, Tokgöz H. Can Hounsfield unit values of the cortex and papillae determined by computed tomography demonstrate the possibility of kidney stone formation? Eur J Radiol. 2012;81:1446–9.CrossRef
10.
go back to reference Ciudin A, Luque Galvez MP, Salvador Izquierdo R, Diaconu MG, de Castro AF, Constantin V, et al. Validation of Randall’s plaque theory using unenhanced abdominal computed tomography. Urology. 2013;81:246–9.CrossRef Ciudin A, Luque Galvez MP, Salvador Izquierdo R, Diaconu MG, de Castro AF, Constantin V, et al. Validation of Randall’s plaque theory using unenhanced abdominal computed tomography. Urology. 2013;81:246–9.CrossRef
11.
go back to reference Shavit L, Girfoglio D, Kirkham A, Allen D, Ferraro PM, Moochhala S, et al. Increased renal papillary density in kidney stone formers detectable by CT scan is a potential marker of stone risk, but is unrelated to underlying hypercalciuria. Urolithiasis. 2016;44:471–5.CrossRef Shavit L, Girfoglio D, Kirkham A, Allen D, Ferraro PM, Moochhala S, et al. Increased renal papillary density in kidney stone formers detectable by CT scan is a potential marker of stone risk, but is unrelated to underlying hypercalciuria. Urolithiasis. 2016;44:471–5.CrossRef
12.
go back to reference Ciudin A, Luque MP, Salvador R, Diaconu MG, Franco A, Collado-Belvis A, et al. The evolution of CT diagnosed papillae tip microcalcifications: can we predict the development of stones? J Endourol. 2014;28:1016–21.CrossRef Ciudin A, Luque MP, Salvador R, Diaconu MG, Franco A, Collado-Belvis A, et al. The evolution of CT diagnosed papillae tip microcalcifications: can we predict the development of stones? J Endourol. 2014;28:1016–21.CrossRef
13.
go back to reference Ciudin A, Luque MP, Salvador R, Diaconu MG, Franco A, Constantin V, et al. Abdominal computed tomography--a new tool for predicting recurrent stone disease. J Endourol. 2013;27:965–9.CrossRef Ciudin A, Luque MP, Salvador R, Diaconu MG, Franco A, Constantin V, et al. Abdominal computed tomography--a new tool for predicting recurrent stone disease. J Endourol. 2013;27:965–9.CrossRef
14.
go back to reference Deshmukh S, Kambadakone A, Sahani DV, Eisner BH. Hounsfield density of renal papillae in stone formers: analysis based on stone composition. J Urol. 2015;193:1560–3.CrossRef Deshmukh S, Kambadakone A, Sahani DV, Eisner BH. Hounsfield density of renal papillae in stone formers: analysis based on stone composition. J Urol. 2015;193:1560–3.CrossRef
15.
go back to reference Cheungpasitporn W, Rossetti S, Friend K, Erickson SB, Lieske JC. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol. 2016;29:211–9.CrossRef Cheungpasitporn W, Rossetti S, Friend K, Erickson SB, Lieske JC. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol. 2016;29:211–9.CrossRef
16.
go back to reference Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29:715-34.CrossRef Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29:715-34.CrossRef
17.
go back to reference Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839–43.CrossRef Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839–43.CrossRef
18.
go back to reference Primiano A, Persichilli S, Gambaro G, Ferraro PM, D’Addessi A, Cocci A, et al. FT-IR analysis of urinary stones: a helpful tool for clinician comparison with the chemical spot test. Dis Markers. 2014;2014:176165.CrossRef Primiano A, Persichilli S, Gambaro G, Ferraro PM, D’Addessi A, Cocci A, et al. FT-IR analysis of urinary stones: a helpful tool for clinician comparison with the chemical spot test. Dis Markers. 2014;2014:176165.CrossRef
Metadata
Title
Changes in renal papillary density after hydration therapy in calcium stone formers
Authors
Pietro Manuel Ferraro
Matteo Vittori
Giuseppe Macis
Alessandro D’Addessi
Gianmarco Lombardi
Claudia Palmisano
Jacopo Gervasoni
Aniello Primiano
Pier Francesco Bassi
Giovanni Gambaro
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2018
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-018-0415-7

Other articles of this Issue 1/2018

BMC Urology 1/2018 Go to the issue